Eosinophil accumulation in rats injected with Sephadex particles.

Area of Science:

• Immunology
• Pharmacology
• Toxicology
• Respiratory Medicine

Background:

• Eosinophils are implicated in various inflammatory lung diseases.
• Understanding the mechanisms of eosinophil-induced lung damage is crucial for developing targeted therapies.
• Sephadex G200 particle injection serves as a model to induce inflammatory responses in vivo.

Purpose of the Study:

• To investigate the effects of repeated Sephadex G200 particle administration on eosinophil levels and lung cell viability in rats.
• To evaluate the protective effects of specific pharmacological agents against Sephadex-induced lung damage.
• To establish a model system for studying eosinophil-mediated lung cell injury.

Main Methods:

• Intravenous injections of Sephadex G200 particles were administered to rats on days 0, 2, and 5.
• Eosinophil counts in blood and lung tissues were measured.
• Lung cell fragility was assessed by quantifying viable cells after in vitro lung tissue digestion.
• The effects of dexamethasone, dapsone, isoprenaline, aspirin, and indomethacin were evaluated.
• In vitro experiments assessed the impact of disrupted and intact eosinophils and other leukocytes on normal lung tissue viability.

Main Results:

• Repeated Sephadex G200 injections significantly increased eosinophil numbers in blood and lung tissues, peaking between days 3-12.
• A parallel increase in lung cell fragility, indicated by reduced cell viability, was observed following repeated injections.
• Dexamethasone, dapsone, and isoprenaline administration attenuated eosinophilia and prevented lung cell death, while aspirin and indomethacin had no effect.
• Disrupted peritoneal eosinophils, but not intact eosinophils or other leukocytes, reduced the viability of normal lung tissue in vitro.

Conclusions:

• Repeated Sephadex G200 administration induces eosinophilia and lung cell damage in rats.
• Certain drugs, including dexamethasone, dapsone, and isoprenaline, demonstrate protective effects against this induced lung injury.
• This study presents a valuable in vivo and in vitro model for investigating eosinophil-associated lung damage and evaluating potential therapeutic interventions.